|
1
|
Ott C and Schölmerich J: Extraintestinal
manifestations and complications in IBD. Nat Rev Gastroenterol
Hepatol. 10:585–595. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Etzel JP, Larson MF, Anawalt BD, Collins J
and Dominitz JA: Assessment and management of low bone density in
inflammatory bowel disease and performance of professional society
guidelines. Inflamm Bowel Dis. 17:2122–2129. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Miznerova E, Hlavaty T, Koller T, Toth J,
Holociova K, Huorka M, Killinger Z and Payer J: The prevalence and
risk factors for osteoporosis in patients with inflammatory bowel
disease. Bratisl Lek Listy. 114:439–445. 2013.PubMed/NCBI
|
|
4
|
Kabbani TA, Koutroubakis IE, Schoen RE,
Ramos-Rivers C, Shah N, Swoger J, Regueiro M, Barrie A, Schwartz M,
Hashash JG, et al: Association of vitamin D level with clinical
status in inflammatory bowel disease: A 5-year longitudinal study.
Am J Gastroenterol. 111:712–719. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Clowes JA, Riggs BL and Khosla S: The role
of the immune system in the pathophysiology of osteoporosis.
Immunol Rev. 208:207–227. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Schulte CM, Dignass AU, Goebell H, Röher
HD and Schulte KM: Genetic factors determine extent of bone loss in
inflammatory bowel disease. Gastroenterology. 119:909–920. 2000.
View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Thearle M, Horlick M, Bilezikian JP, Levy
J, Gertner JM, Levine LS, Harbison M, Berdon W and Oberfield SE:
Osteoporosis: An unusual presentation of childhood Crohn's disease.
J Clin Endocrinol Metab. 85:2122–2126. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
APDW2004 Chinese IBD Working Group.
Retrospective analysis of 515 cases of Crohn's disease
hospitalization in China: Nationwide study from 1990 to 2003. J
Gastroenterol Hepatol. 21:1009–1015. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Harvey RF and Bradshaw JM: A simple index
of Crohn's-disease activity. Lancet. 1:5141980. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Targownik LE, Bernstein CN and Leslie WD:
Inflammatory bowel disease and the risk of osteoporosis and
fracture. Maturitas. 76:315–319. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Phan CM and Guglielmi G: Metabolic bone
disease in patients with malabsorption. Semin Musculoskelet Radiol.
20:369–375. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Lee DY, Jee JH, Cho YY, Jang JY, Yu TY,
Kim TH, Hong YJ, Hong WJ, Jin SM, Hur KY, et al: Serum
25-hydroxyvitamin D cutoffs for functional bone measures in
postmenopausal osteoporosis. Osteoporos Int. 28:1377–1384. 2017.
View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Iseme RA, McEvoy M, Kelly B, Agnew L,
Walker FR and Attia J: Is osteoporosis an autoimmune mediated
disorder? Bone Rep. 7:121–131. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Ofotokun I, Titanji K, Vikulina T,
Roser-Page S, Yamaguchi M, Zayzafoon M, Williams IR and Weitzmann
MN: Role of T-cell reconstitution in HIV-1 antiretroviral
therapy-induced bone loss. Nat Commun. 6:82822015. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Sylvester FA, Wyzga N, Hyams JS and
Gronowicz GA: Effect of Crohn's disease on bone metabolism in
vitro: A role for interleukin-6. J Bone Miner Res. 17:695–702.
2002. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Ali T, Lam D, Bronze MS and Humphrey MB:
Osteoporosis in inflammatory bowel disease. Am J Med. 122:599–604.
2009. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Salem S, Gao C, Li A, Wang H,
Nguyen-Yamamoto L, Goltzman D, Henderson JE and Gros P: A novel
role for interferon regulatory factor 1 (IRF1) in regulation of
bone metabolism. J Cell Mol Med. 18:1588–1598. 2014. View Article : Google Scholar : PubMed/NCBI
|
